Close

More on FULC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-5.1% Growth)
- Ratings (3.3 Score)

Upcoming Events

- Earnings (11/13/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Fulcrum Therapeutics Inc. (NQ:FULC)
Delayed: 3.82 +0.16 (4.37%)
Prev. Close $3.66  
Open$3.72 
52 Wk High$ 
52 Wk Low$ 
Day High$3.84 
Day Low$3.69 
P/E N/A  
EPS$ 
Volume704,059 

Friends, Peers and Foes (?): SNY (more...)

Sep 24, 2024 04:09 PM Fulcrum Therapeutics Inc. (FULC) will reduce its workforce
Sep 24, 2024 04:05 PM Form 8-K Fulcrum Therapeutics, For: Sep 24
Sep 23, 2024 04:16 PM Form 3 Fulcrum Therapeutics, For: Sep 12 Filed by: Kolchinsky Peter
Sep 20, 2024 04:21 PM Form SC 13G Fulcrum Therapeutics, Filed by: TCG Crossover GP II, LLC
Sep 16, 2024 08:21 PM Form SC 13G/A Fulcrum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Sep 13, 2024 04:30 PM Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 13, 2024 06:07 AM H.C. Wainwright Downgrades Fulcrum Therapeutics (FULC) to Neutral
Sep 12, 2024 03:55 PM RBC Capital Downgrades Fulcrum Therapeutics (FULC) to Sector Perform
Sep 12, 2024 12:44 PM Form 8-K Fulcrum Therapeutics, For: Sep 12
Sep 12, 2024 12:20 PM Leerink Partners Downgrades Fulcrum Therapeutics (FULC) to Market Perform
View All Articles

Entities mentioned with FULC

View All Entities